Why BGPT?
logo

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Press Enter ↵ to search evidence



    Explore by Goal









     Quick Explanation


    TFE3 tissue roles table (hepatocyte, muscle, adipocyte, tumor) is below, synthesized from a TFE3 metabolic-regulation review that explicitly covers these cellular contexts and mechanism themes (insulin signaling, glucose/lipid metabolism, lysosomal/autophagy–mitophagy, and cancer-associated programs).



     Long Explanation


    TFE3: tissue-specific roles (hepatocyte, muscle, adipocyte, tumor)
    Evidence source: a TFE3 metabolic-regulation review covering multiple tissue contexts and mechanism themes.
    Evidence grounding & skepticism
    • Known / described: the review explicitly links TFE3 to insulin signaling and glucose/lipid metabolism, plus mitochondrial/autophagy/lysosomal programs in multiple tissues and tumor contexts.
    • Uncertainty: the review notes cross-species/model variability and limitations of overexpression/knockout systems, and that adipose-browning-related conclusions may be context dependent/debated.
    • Reproducibility caveat: synthesized literature—no new primary data are reported in the cited source.
    1) TFE3 tissue-role mapping (table)
    Tissue / context Metabolic program themes linked to TFE3 Mechanistic interactions highlighted Evidence type in the source (as described) Key caveats in the source
    Hepatocyte Insulin signaling alignment; regulation of glucose and lipid metabolism; coupling to mitochondrial/autophagy/lysosomal processes. IRS-2 / FOXO1 / SREBP-1c / PGC-1α axis and broader MiT TF metabolic regulation themes. Synthesized mechanistic evidence; models include mouse liver manipulations and hepatocyte contexts as referenced. Cross-model variability; endogenous vs transgene/KO effects may diverge.
    Muscle (skeletal) Glucose/lipid metabolic control connected to energy-homeostasis programs, with links to mitochondrial/autophagy/lysosomal regulation. Mechanism themes referenced as part of the integrated insulin–metabolism–MiT TF framework. Synthesized tissue-level mechanistic literature across cited models. Context dependence across experimental systems; translational uncertainty.
    Adipocyte Insulin signaling/metabolic regulation with attention to mitochondrial/autophagy–lysosomal coupling; possible role in adipose browning/thermogenic directionality (discussed as debated). Integrated interaction network themes (insulin/FOXO/SREBP/PGC-1α) presented in the review framework. Synthesized evidence including adipose-related mouse models and adipocyte contexts as referenced. Adipose browning conclusions are specifically flagged as conflicting/debated.
    Tumor (e.g., RCC, ASPS) Cancer metabolic reprogramming tied to autophagy/lysosome and mitochondrial dynamics; transcriptional programs driven by TFE3 alterations including fusions. Discussion includes tumor-relevant TFE3 contexts such as Xp11 translocation RCC and alveolar soft part sarcoma, within the TFE3–autophagy/mitochondria metabolic theme. Synthesized cancer mechanistic literature; tumor models and cell line references mentioned in the source description. Model/system differences and variable mechanistic readouts; limited direct clinical data in the review’s framing.
    Table basis: all tissue-role themes in this table are synthesized from the cited review source.
    2) Visual summary: which mechanism themes are emphasized where
    Important limitation: the review provides synthesis, not tissue-by-tissue quantitative coefficients; therefore this plot is qualitative emphasis (0–3) inferred from the described themes, not measured values.
    3) Network diagram: pathway fragments mentioned in the source
    Source-limited scope: only interaction fragments explicitly mentioned in the review excerpt description are shown (IRS-2/FOXO1/SREBP-1c/PGC-1α and REV-ERBα, plus mitochondrial/autophagy–lysosome and glucose/lipid metabolism themes).
    What would falsify or strongly change this tissue-role map?
    • Loss-of-function in a given tissue (e.g., liver or adipose) would not alter insulin sensitivity or glucose/lipid metabolism as claimed by the integrated model.
    • TFE3 manipulation would not shift the proposed regulatory targets (IRS-2/FOXO1/SREBP-1c/PGC-1α-related gene expression changes).
    • For adipose browning/thermogenic claims, in vivo TFE3 activity would not produce the proposed effects under defined conditions—particularly given the review’s stated debate/conflicting findings.
    Single-source limitation: In this response, the tissue mapping is grounded only in the provided review record.


    Feedback:    

    Updated: April 11, 2026

     Hypothesis Graveyard


    A simplistic “TFE3 always increases insulin sensitivity” model is unlikely to hold across tissues because the source flags cross-model/species variability and conflicting adipose outcomes, implying bidirectionality or context dependence.


    A “TFE3’s main role is only mitochondrial dynamics, not lysosome/autophagy” explanation is disfavored by the review’s explicit emphasis on mitochondrial/autophagy and lysosomal biogenesis coupling.

     Science Art


    Create Tables: TFE3 tissue specific roles (hepatocyte, muscle, adipocyte, tumor) Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending